Abstract
Purpose of Review
This review will discuss the current methods employed in military trauma systems to care for combat casualties, with emphasis on what is referred to in NATO doctrine as “Role 1” and “Role 2” medical support—that is, care of the war-injured patient at the point of injury and, slightly further “upstream” in the trauma system in a forward, mobile trauma system.
Recent Findings
Tactical Combat Casualty Care is continuously updated by the Joint Trauma System in a rigorous manner. New technologies and procedures are constantly being investigated and adapted to the tactical demands of the battlefield. The most significant recent developments are the introduction of tranexamic acid, the advent of 1:1:1 blood product therapy, widespread use of tourniquets, and lyophilized or “freeze-dried” plasma to overcome the barriers inherent in frozen plasma.
Summary
Current doctrine in military medicine is the ultimate expression of damage control resuscitation. Realities of the modern battlefield often necessitate novel approaches to care that emphasize mobility over robustness and temporizing measures over definitive. While these methods would perhaps seem suboptimal to the civilian trauma surgeon, the preventable mortality in the recent conflicts in Iraq and Afghanistan was lower than for any other modern war [1], and fell after the lessons of the early phases of the wars lead to development of the prehospital guidelines developed by the Committee on Tactical Combat Casualty Care (TCCC), now overseen by the Joint Trauma System (JTS) [2, 3]. The JTS oversees the delivery of trauma care to war-wounded personnel from point of injury to convalescence in the continental USA. It regularly updates its clinical practice guidelines [3]. Controlling hemorrhage, the primary cause of preventable battlefield deaths (>80%) [4, 5] is the primary goal in TCCC and the JTS. Far from being applicable only to combat trauma, the lessons learned in the recent wars have tangible benefits in disaster response and mass civilian trauma, particularly in this age of seemingly random mass shootings in the US and assorted terror attacks in Europe and throughout the world. This review will describe the system in which the US Armed Forces delivers care to patients injured on the modern battlefield, the tenants that guide that care, and the scientific basis for the most current developments in the field.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40719-017-0088-9/MediaObjects/40719_2017_88_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40719-017-0088-9/MediaObjects/40719_2017_88_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40719-017-0088-9/MediaObjects/40719_2017_88_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40719-017-0088-9/MediaObjects/40719_2017_88_Fig4_HTML.gif)
Similar content being viewed by others
References
Eastridge BJ, et al. Trauma system development in a theater of war: experiences for Operation Iraqi Freedom and Operation Enduring Freedom. J Trauma. 2006;198(6):852–7.
Eastridge BJ, Costanzo G, Jenkins D, et al. Impact of joint theater trauma system initiatives on battlefield injury outcomes. Am J Surg. 2010;198:852–7.
Joint Trauma System: Clinical Practice Guidelines http://www.usaisr.amedd.army.mil/cpgs.html
Holcomb JB, McMullen NR, Pearse L, Caruso J, Wade CE, OetjenGerdes L, Champion HR, Lawnick M, Farr W, Rodriguez S, et al. Causes of death in US Special Operations Forces in the global war on terrorism: 2001–2004. Ann Surg. 2007;245:986–91.
Kelly JF, Ritenhour AE, McLaughlin DF, et al. Injury severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003–2004 versus 2006. J Trauma. 2008;64:S21–7.
Committee on Tactical Combat Casualty Care: Tactical Combat Casualty Care Guidelines. http://www.usaisr.amedd.army.mil/jts_ccc_course.html
Eastridge BJ, et al. Forward surgical teams provide comparable outcomes to combat support hospitals during support and stabilization operations on the battlefield. J Trauma. 2009;66(4 Supp):48–50.
Butler FK, Hagmann J, Butler EG. Tactical combat casualty care in special operations. Mil Med. 1996;161(suppl):1–15.
Kotwal, et al. Eliminating preventable death on the battlefield. Arch Surg. 2011;146(12):1350–8.
Committee on Tactical Combat Casualty Care: TCCC Curriculum. http://www.usaisr.amedd.army.mil/jts_ccc_course_CURRICULUM.html
Butler, et al. Battlefield trauma care then and now: a decade of Tactical Combat Casualty Care J Trauma Acute Care Surg, Volume 73, Number 6, Supplement 5.
Krahg JF, et al. Practical use of emergency tourniquets to stop bleeding in major limb trauma. J Trauma. 2008;64(2 supp):S38–49.
Beekley AC, et al. Prehospital tourniquet use in Operation Iraqi Freedom: effect on hemorrhage control and outcomes. J Trauma. 2008;64(2 Suppl):S28–37.
Meusnier JG, et al. Evaluation of two junctional tourniquets used on the battlefield: Combat Ready Clamp® versus SAM® junctional tourniquet. J Spec Oper Med. 2016;16(3):41–6.
Kragh JF. Performance of junctional tourniquets in normal human volunteers. Prehosp Emerg Care. 2015;19(3):391–8.
Mesar T, et al. Human dose confirmation for self-expanding intra-abdominal foam: a translational, adaptive, multicenter trial in recently deceased human subjects. J Trauma Acute Care Surg. 79(1):39–46.
Lyon M, et al. Use of abdominal aortic tourniquet to reduce or eliminate flow in the common femoral artery in human subjects. J Trauma Acure Care Surg. 2012 Aug;73(2 Suppl 1):S103–5.
Kheirabadi BS, et al. Physiological consequences of abdominal aortic and junctional tourniquet (AAJT) application to control hemorrhage in a swine model. Shock. 2016;46(3 Suppl 1):160–6.
Daniel Y, Habas S, Malan L, et al. Tactical damage control resuscitation in austere military environments. J R Army Med Corps. 2016;162:419–27.
Holcomb J. Fluid resuscitation in modern combat casualty care: lessons learned in Somalia. J Trauma. 2003;54:S46YS51.
Schreiber MA, Meier EN, Tisherman SA, et al. A controlled resuscitation strategy is feasible and safe in hypotensive trauma patients: results of a prospective randomized pilot trial. J Trauma Acute Care Surg. 2015;78:687–95. discussion 695–697
Moore HB, Moore EE, Gonzalez E, et al. Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage. J Am Coll Surg. 2015;220:872–9.
Pusateri AE, Given MB, Schreiber MA, et al. Dried plasma: state of the science and recent developments. Transfusion. 2016 Apr;56(Suppl 2):S128–39. doi:10.1111/trf.13580.
Jeffrey Soares. USAMMDA and freeze-dried plasma: a story of success. https://www.army.mil/article/174904/usammda_and_freeze_dried_plasma_a_story_of_success
Martinaud, et al. Use of freeze-dried plasma in French intensive care unit in Afghanistan. J Trauma. 2011;71(6):1761–4.
Holcomb JB. Damage control resuscitation. J Trauma. 2007;62(6 Suppl):S36–7.
Nessen, et al. Fresh whole blood use by forward surgical teams in Afghanistan is associated with improved survival compared to component therapy without platelets. Transfusion. 2013;53(Suppl 1):107S–13S.
Borgman MA, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63(4):805–13.
Morrison JJ, Ross JD, Poon H, Midwinter MJ, Jansen JO. Intra-operative correction of acidosis, coagulopathy and hypothermia in combat casualties with severe haemorrhagic shock. Anaesthesia. 2013;68:846Y850.
Holcomb JB, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;3; 312(5):471–82.
Ives C, Inaba K, Branco BC, et al. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg. 2012;215:496–502.
Moore HB, Moore EE, Gonzalez E, et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg. 2014;77:811–7.
Schochl H, Voelckel W, Maegele M, Solomon C. Trauma-associated hyperfibrinolysis. Hamostaseologie. 2012;32:22–7.
Napolitano LM, et al. Tranexamic acid in trauma. J Trauma Acute Care Surg. 74:1575–86.
CRASH-2 Collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlled trial. Lancet. 2011;377:1096–101.
Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military application of tranexamic acid in trauma emergency resuscitation study (MATTERs). Arch Surg. 2011;147:113–9.
Eckert MJ, Wertin TM, Tyner SD, Nelson DW, Izenberg SI, Martin MJ. Tranexamic acid administration to pediatric trauma patients in a combat setting: the pediatric trauma and tranexamic acid study (PED-TRAX). J Trauma and Acute Care Surg. 2014;77:852–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on The Military Perspective
Rights and permissions
About this article
Cite this article
Davis, B.L., Martin, M.J. & Schreiber, M. Military Resuscitation: Lessons from Recent Battlefield Experience. Curr Trauma Rep 3, 156–163 (2017). https://doi.org/10.1007/s40719-017-0088-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40719-017-0088-9